Viagra-like drug approved in US to help women with libido

REGULATORS in the US have approved a drug that some describe as the first female Viagra.

The drug, flibanserin, to be sold under the name Addyi, has received the go-ahead from the Food and Drug Administration after being knocked back in 2010 and 2013.

It works on neurotransmitters in the brain to boost the libido of women who have lost interest in sex. It is intended to treat women who have not yet entered menopause and who have hypoactive sexual desire disorder (HSDD).

The director of the FDA's Centre for Drug Evaluation and Research, Janet Woodcock, told AFP: "Today's approval provides women distressed by their low sexual desire with an approved treatment option."

The FDA warns, however, the drug can have side-effects - including nausea, dizziness, sleepiness and low blood pressure - and must not be taken with alcohol.

"Patients and prescribers should fully understand the risks associated with the use of Addyi before considering treatment," Ms Woodcock said.

The disorder can reportedly develop in women who previously have been sexually active.



FLUORIDE DEBATE: Deputy mayor calls for vote this year

premium_icon FLUORIDE DEBATE: Deputy mayor calls for vote this year

Medical bodies call for council to reverse 2016 decision.

Endeavour adventure for the high seas

Endeavour adventure for the high seas

STS Young Endeavour spent several days berthed at Gladstone Marina

GALLERY: Gladstone Eisteddfod excites with dance routines

premium_icon GALLERY: Gladstone Eisteddfod excites with dance routines

Gladstone Eisteddfod returns after one months absence.

Local Partners